Keywords
Low back pain, lumbar facet joint syndrome, autologous platelet rich plasma (PRP), intra-articular injection.
Summary
The study found that the injection was effective in reducing pain and improving function in the short-term (3 months). Specifically, the injection significantly reduced pain levels at rest and during movement. It also significantly improved function, as measured by the Oswestry Disability Index (ODI). The ODI is a validated questionnaire that is used to assess the level of disability caused by low back pain.
The study also found that the injection was safe. There were no serious adverse events reported. The most common side effects were bruising and soreness at the injection site.
A total 19 patients with lumbar facet joint syndrome were enrolled to receive lumbar facet joint injection with autologous PRP under x-ray fluoroscopic control. Patients were followed up immediately, at one week, one month, 2 months, and 3 months following treatment.
At one week after treatment, low back pain reduced significantly compared with prior to treatment both at rest and during flexion. The outcomes were assessed as “good” or “excellent” for 9 patients (47.37%) immediately after treatment, 14 patients (73.68%) at
one week, 15 patients (78.95%) at one month, 15 patients (78.95%) at 2 months, and 15 patients (78.95%) at 3 months.
Conclusion
In the short-term period of 3 months, the new technique of lumbar facet joint injection with autologous PRP is effective and safe for patients with lumbar facet joint syndrome.
Support available at Surecell
Our Surecell doctors are musculoskeletal experts who provide regenerative medicine treatments for osteoarthritis, such as platelet-rich plasma (PRP). Feel free to contact our friendly staff on 03 9822 9996 or submit an enquiry here.
Learn more about the treatments Surecell has to offer on our Services page.